Pharmaceutical
SkyePharma PLC announces AGM Statement
00:02 Jun 29, 2007
Anticus International Corporation Will Build and Operate a Demonstration Unit in Quebec City, Canada
Anticus International Corporation a public traded company on the OTC:PK exchange is pleased to announce that it has signed an agreement with a private Canadian Research and Development company. For Anticus, they will build and operate a demonstration uni
15:04 Jun 28, 2007
Cytokinetics, Incorporated announced results from the analyses of three Phase II clinical trials of ispinesib administered as monotherapy, one in patients with hepatocellular cancer, one in patients with melanoma, and one in patients with hormone-refract
14:05 Jun 28, 2007
Cytokinetics, Incorporated announced today the final results from a multicenter Phase II clinical trial sponsored by GlaxoSmithKline , which evaluated ispinesib in patients with locally advanced or metastatic breast cancer. Ispinesib is a novel small mol
14:00 Jun 28, 2007
Safety of Anti-Anemia Drugs for Chemotherapy Patients Questioned; This Week on Your Cancer Today(TM)
On this week's program, we discuss lifestyle and environmental factors and the role they play in the development of colon cancer.
13:00 Jun 28, 2007
Smith & Nephew PLC
11:48 Jun 28, 2007
Red Mountain Pharmaceuticals, Inc. announced the addition of Mr. Carter D. Womack to the Board of Directors. 'Mr. Womack brings to RMPI that key ingredient which every successful company must have. That is strong leadership and the ability to lead both i
09:57 Jun 28, 2007
The CEO of IDenta Corp. issued a statement today that provides some additional information on Tuesday's official statement concerning recent buy-out and merger offers.
08:22 Jun 28, 2007
Millennium Pharmaceuticals, Inc. today reported on the presentation of results from four clinical trials of VELCADE based therapies that showed consistently high survival and complete remission / complete response rates in newly diagnosed multiple myelom
08:00 Jun 28, 2007
Shine Holdings, Inc. has announced today the filing of a provisional patent for a remediation process against possible bioterror agents such as anthrax, botulism, and viruses that might be deliberately released in water. The process is for a tri-use ozon
07:54 Jun 28, 2007
Cavit Sciences, Inc. today announced the securing of its intellectual property rights in major countries throughout the world.
07:05 Jun 28, 2007
Serenex, Inc., an integrated drug discovery and development company, announced today that it has secured $31 million in financing. The round comprises a $26 million Series D private placement of preferred stock and a $5 million working capital debt facil
07:00 Jun 28, 2007
QuantRx® Biomedical Corporation , an emerging leader in the research and development of medical diagnostic platforms and products, today announced that FluoroPharma, a QuantRx affiliate, completed 12 healthy volunteers in a Phase I clinical trial fo
06:26 Jun 28, 2007
Molecular Biometrics , a privately held metabolomics company, today announced that researchers will present results of three clinical studies investigating the use of ViaTest-E, the Company's non-invasive platform designed to assess embryo and gamete via
06:15 Jun 28, 2007
Targeted Genetics Corporation today announced the completion of its private equity offering of 6.7 million shares of its common stock at a purchase price of $2.905 per share, together with warrants to purchase up to an aggregate of 6.7 million shares of
05:30 Jun 28, 2007
© Copyright 2009 Baret News
